In lung cancer, specific genetic mutations, such as STK11, EGFR, FAT1, SETBP1, KRAS, and TP53, have been predicted with an AUC range of 0.733–0.856, which was externally validated29. This evidence concerns the gene STK11 and lung carcinoma.